{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T23:59:41Z","timestamp":1789603181987,"version":"build-2803163510"},"reference-count":235,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100006686","name":"University of Miami","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006686","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL128714"],"award-info":[{"award-number":["R01HL128714"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000041","name":"American Diabetes Association","doi-asserted-by":"publisher","award":["1-16-IBS-087"],"award-info":[{"award-number":["1-16-IBS-087"]}],"id":[{"id":"10.13039\/100000041","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","thebonejournal.com","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.bone.2016.10.001","type":"journal-article","created":{"date-parts":[[2016,10,11]],"date-time":"2016-10-11T01:15:28Z","timestamp":1476148528000},"page":"69-79","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"special_numbering":"C","title":["Cardiac actions of fibroblast growth factor 23"],"prefix":"10.1016","volume":"100","author":[{"given":"Christian","family":"Faul","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2016.10.001_bb0005","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1056\/NEJMra072139","article-title":"Cardiac plasticity","volume":"358","author":"Hill","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bone.2016.10.001_bb0010","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1161\/CIRCULATIONAHA.113.001878","article-title":"Pathological ventricular remodeling: mechanisms: part 1 of 2","volume":"128","author":"Burchfield","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.bone.2016.10.001_bb0015","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1146\/annurev.physiol.65.092101.142243","article-title":"Cardiac hypertrophy: the good, the bad, and the ugly","volume":"65","author":"Frey","year":"2003","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.bone.2016.10.001_bb0020","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/jcp.22322","article-title":"The origin of fibroblasts and mechanism of cardiac fibrosis","volume":"225","author":"Krenning","year":"2010","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.bone.2016.10.001_bb0025","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1161\/CIRCRESAHA.109.209809","article-title":"Cardiac fibroblast: the renaissance cell","volume":"105","author":"Souders","year":"2009","journal-title":"Circ. Res."},{"key":"10.1016\/j.bone.2016.10.001_bb0030","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1146\/annurev.ph.53.030191.001143","article-title":"Growth factors, proto-oncogenes, and plasticity of the cardiac phenotype","volume":"53","author":"Parker","year":"1991","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.bone.2016.10.001_bb0035","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1161\/01.RES.0000046452.67724.B8","article-title":"Gene expression in fibroblasts and fibrosis: involvement in cardiac hypertrophy","volume":"91","author":"Manabe","year":"2002","journal-title":"Circ. Res."},{"key":"10.1016\/j.bone.2016.10.001_bb0040","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.tem.2013.12.002","article-title":"New insights into IGF-1 signaling in the heart","volume":"25","author":"Troncoso","year":"2014","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.bone.2016.10.001_bb0045","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nrm3495","article-title":"Molecular basis of physiological heart growth: fundamental concepts and new players","volume":"14","author":"Maillet","year":"2013","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bone.2016.10.001_bb0050","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/cvr\/cvu013","article-title":"Pregnancy as a cardiac stress model","volume":"101","author":"Chung","year":"2014","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bone.2016.10.001_bb0055","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/nm0502-459","article-title":"ErbB2 is essential in the prevention of dilated cardiomyopathy","volume":"8","author":"Crone","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.bone.2016.10.001_bb0060","doi-asserted-by":"crossref","first-page":"8880","DOI":"10.1073\/pnas.122249299","article-title":"Conditional mutation of the ErbB2 (HER2) receptor in cardiomyocytes leads to dilated cardiomyopathy","volume":"99","author":"Ozcelik","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bone.2016.10.001_bb0065","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/j.yjmcc.2003.09.012","article-title":"Neuregulin-1 protects ventricular myocytes from anthracycline-induced apoptosis via erbB4-dependent activation of PI3-kinase\/Akt","volume":"35","author":"Fukazawa","year":"2003","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.bone.2016.10.001_bb0070","doi-asserted-by":"crossref","first-page":"19469","DOI":"10.1074\/jbc.M600399200","article-title":"Role of neuregulin-1\/ErbB2 signaling in endothelium-cardiomyocyte cross-talk","volume":"281","author":"Lemmens","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bone.2016.10.001_bb0075","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1161\/CIRCULATIONAHA.107.690487","article-title":"Role of neuregulin-1\/ErbB signaling in cardiovascular physiology and disease: implications for therapy of heart failure","volume":"116","author":"Lemmens","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.bone.2016.10.001_bb0080","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1161\/CIRCRESAHA.109.205906","article-title":"The vulnerability of the heart as a pluricellular paracrine organ: lessons from unexpected triggers of heart failure in targeted ErbB2 anticancer therapy","volume":"106","author":"De Keulenaer","year":"2010","journal-title":"Circ. Res."},{"key":"10.1016\/j.bone.2016.10.001_bb0085","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3389\/fphys.2013.00247","article-title":"Pathophysiological roles of FGF signaling in the heart","volume":"4","author":"Itoh","year":"2013","journal-title":"Front. Physiol."},{"key":"10.1016\/j.bone.2016.10.001_bb0090","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.tig.2004.08.007","article-title":"Evolution of the Fgf and Fgfr gene families","volume":"20","author":"Itoh","year":"2004","journal-title":"Trends Genet."},{"key":"10.1016\/j.bone.2016.10.001_bb0095","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0074-7696(08)60149-7","article-title":"Fibroblast growth factors as multifunctional signaling factors","volume":"185","author":"Szebenyi","year":"1999","journal-title":"Int. Rev. Cytol."},{"key":"10.1016\/j.bone.2016.10.001_bb0100","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.cytogfr.2005.01.001","article-title":"Cellular signaling by fibroblast growth factor receptors","volume":"16","author":"Eswarakumar","year":"2005","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.bone.2016.10.001_bb0105","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/jb\/mvq121","article-title":"Fibroblast growth factors: from molecular evolution to roles in development, metabolism and disease","volume":"149","author":"Itoh","year":"2011","journal-title":"J. Biochem."},{"key":"10.1016\/j.bone.2016.10.001_bb0110","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.neuron.2007.07.006","article-title":"Fibroblast growth factor homologous factors control neuronal excitability through modulation of voltage-gated sodium channels","volume":"55","author":"Goldfarb","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.bone.2016.10.001_bb0115","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.mcn.2009.05.007","article-title":"FGF14 N-terminal splice variants differentially modulate Nav1.2 and Nav1.6-encoded sodium channels","volume":"42","author":"Laezza","year":"2009","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.bone.2016.10.001_bb0120","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/0092-8674(91)90512-W","article-title":"Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor","volume":"64","author":"Yayon","year":"1991","journal-title":"Cell"},{"key":"10.1016\/j.bone.2016.10.001_bb0125","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1126\/science.1646484","article-title":"Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation","volume":"252","author":"Rapraeger","year":"1991","journal-title":"Science"},{"key":"10.1016\/j.bone.2016.10.001_bb0130","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/0092-8674(94)90032-9","article-title":"Heparin-induced oligomerization of FGF molecules is responsible for FGF receptor dimerization, activation, and cell proliferation","volume":"79","author":"Spivak-Kroizman","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.bone.2016.10.001_bb0135","doi-asserted-by":"crossref","first-page":"3417","DOI":"10.1128\/MCB.02249-06","article-title":"Molecular insights into the klotho-dependent, endocrine mode of action of fibroblast growth factor 19 subfamily members","volume":"27","author":"Goetz","year":"2007","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bone.2016.10.001_bb0140","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1021\/bi035320k","article-title":"The crystal structure of fibroblast growth factor (FGF) 19 reveals novel features of the FGF family and offers a structural basis for its unusual receptor affinity","volume":"43","author":"Harmer","year":"2004","journal-title":"Biochemistry"},{"key":"10.1016\/j.bone.2016.10.001_bb0145","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.cytogfr.2005.01.008","article-title":"Structural basis for fibroblast growth factor receptor activation","volume":"16","author":"Mohammadi","year":"2005","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.bone.2016.10.001_bb0150","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/nature05315","article-title":"Klotho converts canonical FGF receptor into a specific receptor for FGF23","volume":"444","author":"Urakawa","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.bone.2016.10.001_bb0155","doi-asserted-by":"crossref","first-page":"6120","DOI":"10.1074\/jbc.C500457200","article-title":"Regulation of fibroblast growth factor-23 signaling by klotho","volume":"281","author":"Kurosu","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bone.2016.10.001_bb0160","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/36285","article-title":"Mutation of the mouse klotho gene leads to a syndrome resembling ageing","volume":"390","author":"Kuro-o","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.bone.2016.10.001_bb0165","first-page":"4003","article-title":"The parathyroid is a target organ for FGF23 in rats","volume":"117","author":"Ben-Dov","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bone.2016.10.001_bb0170","doi-asserted-by":"crossref","DOI":"10.1186\/gb-2001-2-3-reviews3005","article-title":"Fibroblast growth factors","volume":"2","author":"Ornitz","year":"2001","journal-title":"Genome Biol."},{"key":"10.1016\/j.bone.2016.10.001_bb0175","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/nrc2780","article-title":"Fibroblast growth factor signalling: from development to cancer","volume":"10","author":"Turner","year":"2010","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bone.2016.10.001_bb0180","doi-asserted-by":"crossref","first-page":"5068","DOI":"10.1128\/MCB.11.10.5068","article-title":"A tyrosine-phosphorylated carboxy-terminal peptide of the fibroblast growth factor receptor (Flg) is a binding site for the SH2 domain of phospholipase C-gamma 1","volume":"11","author":"Mohammadi","year":"1991","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bone.2016.10.001_bb0185","doi-asserted-by":"crossref","first-page":"18320","DOI":"10.1016\/S0021-9258(17)32309-8","article-title":"Signal transduction by fibroblast growth factor receptor-4 (FGFR-4). Comparison with FGFR-1","volume":"269","author":"Vainikka","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bone.2016.10.001_bb0190","doi-asserted-by":"crossref","first-page":"4770","DOI":"10.1128\/MCB.10.9.4770","article-title":"Characterization and cDNA cloning of phospholipase C-gamma, a major substrate for heparin-binding growth factor 1 (acidic fibroblast growth factor)-activated tyrosine kinase","volume":"10","author":"Burgess","year":"1990","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bone.2016.10.001_bb0195","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S0092-8674(00)80252-4","article-title":"A lipid-anchored Grb2-binding protein that links FGF-receptor activation to the Ras\/MAPK signaling pathway","volume":"89","author":"Kouhara","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.bone.2016.10.001_bb0200","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1210\/me.2010-0142","article-title":"Research resource: comprehensive expression atlas of the fibroblast growth factor system in adult mouse","volume":"24","author":"Fon Tacer","year":"2010","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.bone.2016.10.001_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmet.2015.09.002","article-title":"Activation of cardiac fibroblast growth factor receptor 4 causes left ventricular hypertrophy","author":"Grabner","year":"2015","journal-title":"Cell Metab."},{"key":"10.1016\/j.bone.2016.10.001_bb0210","article-title":"Induction of cardiac FGF23\/FGFR4 expression is associated with left ventricular hypertrophy in patients with chronic kidney disease","author":"Leifheit-Nestler","year":"2015","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.bone.2016.10.001_bb0215","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1177\/002215549704500710","article-title":"Differential expression of the fibroblast growth factor receptor (FGFR) multigene family in normal human adult tissues","volume":"45","author":"Hughes","year":"1997","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.bone.2016.10.001_bb0220","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/S0008-6363(99)00008-5","article-title":"Overexpression of long or short FGFR-1 results in FGF-2-mediated proliferation in neonatal cardiac myocyte cultures","volume":"42","author":"Sheikh","year":"1999","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bone.2016.10.001_bb0225","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.ijcard.2010.07.024","article-title":"Acidic and basic fibroblast growth factors involved in cardiac angiogenesis following infarction","volume":"152","author":"Zhao","year":"2011","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.bone.2016.10.001_bb0230","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1161\/01.RES.71.2.251","article-title":"Acidic and basic fibroblast growth factors in adult rat heart myocytes. Localization, regulation in culture, and effects on DNA synthesis","volume":"71","author":"Speir","year":"1992","journal-title":"Circ. Res."},{"key":"10.1016\/j.bone.2016.10.001_bb0235","first-page":"H1927","article-title":"Adult cardiomyocytes express functional high-affinity receptors for basic fibroblast growth factor","volume":"268","author":"Liu","year":"1995","journal-title":"Am. J. Phys."},{"key":"10.1016\/j.bone.2016.10.001_bb0240","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0082979","article-title":"Fibroblast growth factor receptor 1 signaling in adult cardiomyocytes increases contractility and results in a hypertrophic cardiomyopathy","volume":"8","author":"Cilvik","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bone.2016.10.001_bb0245","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.devcel.2004.12.002","article-title":"Endocardial and epicardial derived FGF signals regulate myocardial proliferation and differentiation in vivo","volume":"8","author":"Lavine","year":"2005","journal-title":"Dev. Cell"},{"key":"10.1016\/j.bone.2016.10.001_bb0250","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.1242\/dev.064410","article-title":"FGF10\/FGFR2b signaling is essential for cardiac fibroblast development and growth of the myocardium","volume":"138","author":"Vega-Hernandez","year":"2011","journal-title":"Development"},{"key":"10.1016\/j.bone.2016.10.001_bb0255","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.cardiores.2006.03.021","article-title":"Congenital heart defects in Fgfr2-IIIb and Fgf10 mutant mice","volume":"71","author":"Marguerie","year":"2006","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bone.2016.10.001_bb0260","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1242\/dev.113.2.641","article-title":"FGFR-4, a new member of the fibroblast growth factor receptor family, expressed in the definitive endoderm and skeletal muscle lineages of the mouse","volume":"113","author":"Stark","year":"1991","journal-title":"Development"},{"key":"10.1016\/j.bone.2016.10.001_bb0265","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1002\/j.1460-2075.1991.tb07654.x","article-title":"FGFR-4, a novel acidic fibroblast growth factor receptor with a distinct expression pattern","volume":"10","author":"Partanen","year":"1991","journal-title":"EMBO J."},{"key":"10.1016\/j.bone.2016.10.001_bb0270","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1158\/0008-5472.CAN-09-3239","article-title":"A single nucleotide change in the mouse genome accelerates breast cancer progression","volume":"70","author":"Seitzer","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.bone.2016.10.001_bb0275","doi-asserted-by":"crossref","first-page":"H1071","DOI":"10.1152\/ajpheart.00290.2001","article-title":"Acute protection of ischemic heart by FGF-2: involvement of FGF-2 receptors and protein kinase C","volume":"282","author":"Jiang","year":"2002","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.bone.2016.10.001_bb0280","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1006\/jmcc.1998.0654","article-title":"Intramyocardial infusion of FGF-1 mimics ischemic preconditioning in pig myocardium","volume":"30","author":"Htun","year":"1998","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.bone.2016.10.001_bb0285","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.cell.2006.08.052","article-title":"A dynamic epicardial injury response supports progenitor cell activity during zebrafish heart regeneration","volume":"127","author":"Lepilina","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.bone.2016.10.001_bb0290","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1093\/ajh\/hpt177","article-title":"Paricalcitol downregulates myocardial renin-angiotensin and fibroblast growth factor expression and attenuates cardiac hypertrophy in uremic rats","volume":"27","author":"Freundlich","year":"2014","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.bone.2016.10.001_bb0295","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1093\/eurheartj\/ehq436","article-title":"Cardioprotective effect of calcineurin inhibition in an animal model of renal disease","volume":"32","author":"Di Marco","year":"2011","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.bone.2016.10.001_bb0300","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1038\/bjc.2012.103","article-title":"Cross-suppression of EGFR ligands amphiregulin and epiregulin and de-repression of FGFR3 signalling contribute to cetuximab resistance in wild-type KRAS tumour cells","volume":"106","author":"Oliveras-Ferraros","year":"2012","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bone.2016.10.001_bb0305","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1042\/BJ20101603","article-title":"Fibroblast growth factors and their receptors in cancer","volume":"437","author":"Wesche","year":"2011","journal-title":"Biochem. J."},{"key":"10.1016\/j.bone.2016.10.001_bb0310","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1093\/toxsci\/kft161","article-title":"Pan-FGFR inhibition leads to blockade of FGF23 signaling, soft tissue mineralization, and cardiovascular dysfunction","volume":"135","author":"Yanochko","year":"2013","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.bone.2016.10.001_bb0315","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.cardiores.2004.04.024","article-title":"Fibroblast growth factor 2 isoforms and cardiac hypertrophy","volume":"63","author":"Kardami","year":"2004","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bone.2016.10.001_bb0320","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s10741-007-9027-0","article-title":"Fibroblast growth factor-2 and cardioprotection","volume":"12","author":"Kardami","year":"2007","journal-title":"Heart Fail. Rev."},{"key":"10.1016\/j.bone.2016.10.001_bb0325","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1093\/cvr\/27.7.1150","article-title":"Fibroblast and transforming growth factor expression in the cardiac myocyte","volume":"27","author":"Cummins","year":"1993","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bone.2016.10.001_bb0330","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1172\/JCI114466","article-title":"Peptide growth factors can provoke \"fetal\" contractile protein gene expression in rat cardiac myocytes","volume":"85","author":"Parker","year":"1990","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bone.2016.10.001_bb0335","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1172\/JCI118414","article-title":"Role of transiently altered sarcolemmal membrane permeability and basic fibroblast growth factor release in the hypertrophic response of adult rat ventricular myocytes to increased mechanical activity in vitro","volume":"97","author":"Kaye","year":"1996","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bone.2016.10.001_bb0340","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1161\/01.RES.81.5.679","article-title":"Trophic effect of human pericardial fluid on adult cardiac myocytes. Differential role of fibroblast growth factor-2 and factors related to ventricular hypertrophy","volume":"81","author":"Corda","year":"1997","journal-title":"Circ. Res."},{"key":"10.1016\/j.bone.2016.10.001_bb0345","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1172\/JCI13627","article-title":"Dilated cardiomyopathy and impaired cardiac hypertrophic response to angiotensin II in mice lacking FGF-2","volume":"108","author":"Pellieux","year":"2001","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bone.2016.10.001_bb0350","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0097281","article-title":"High molecular weight fibroblast growth factor-2 in the human heart is a potential target for prevention of cardiac remodeling","volume":"9","author":"Santiago","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.bone.2016.10.001_bb0355","doi-asserted-by":"crossref","first-page":"17361","DOI":"10.1074\/jbc.270.29.17361","article-title":"Basic fibroblast growth factor activates calcium channels in neonatal rat cardiomyocytes","volume":"270","author":"Merle","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bone.2016.10.001_bb0360","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s12012-015-9315-1","article-title":"FGF2 prevents sunitinib-induced cardiotoxicity in zebrafish and cardiomyoblast H9c2 cells","volume":"16","author":"Cui","year":"2016","journal-title":"Cardiovasc. Toxicol."},{"key":"10.1016\/j.bone.2016.10.001_bb0365","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/S0021-9258(17)42228-9","article-title":"Endothelin-1 and fibroblast growth factors stimulate the mitogen-activated protein kinase signaling cascade in cardiac myocytes. The potential role of the cascade in the integration of two signaling pathways leading to myocyte hypertrophy","volume":"269","author":"Bogoyevitch","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bone.2016.10.001_bb0370","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1006\/jmcc.1998.0832","article-title":"FGF-2-induced negative inotropism and cardioprotection are inhibited by chelerythrine: involvement of sarcolemmal calcium-independent protein kinase C","volume":"30","author":"Padua","year":"1998","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.bone.2016.10.001_bb0375","doi-asserted-by":"crossref","first-page":"H1039","DOI":"10.1152\/ajpheart.2001.280.3.H1039","article-title":"Overexpression of FGF-2 increases cardiac myocyte viability after injury in isolated mouse hearts","volume":"280","author":"Sheikh","year":"2001","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.bone.2016.10.001_bb0380","first-page":"143","article-title":"Fibroblast growth factor 2 mediates isoproterenol-induced cardiac hypertrophy through activation of the extracellular regulated kinase","volume":"2","author":"House","year":"2010","journal-title":"Mol. Cell. Pharmacol."},{"key":"10.1016\/j.bone.2016.10.001_bb0385","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1042\/CS20070430","article-title":"MAPK signalling in cardiovascular health and disease: molecular mechanisms and therapeutic targets","volume":"115","author":"Muslin","year":"2008","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.bone.2016.10.001_bb0390","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1139\/o99-059","article-title":"Fibroblast growth factor-2 stimulates phospholipase Cbeta in adult cardiomyocytes","volume":"77","author":"Tappia","year":"1999","journal-title":"Biochem. Cell Biol."},{"key":"10.1016\/j.bone.2016.10.001_bb0395","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/shk.0b013e318123e822","article-title":"Calreticulin downregulation is associated with FGF-2-induced angiogenesis through calcineurin pathway in ischemic myocardium","volume":"29","author":"Liu","year":"2008","journal-title":"Shock"},{"key":"10.1016\/j.bone.2016.10.001_bb0400","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1080\/15419060600631326","article-title":"Administration of FGF-2 to the heart stimulates connexin-43 phosphorylation at protein kinase C target sites","volume":"13","author":"Srisakuldee","year":"2006","journal-title":"Cell Commun. Adhes."},{"key":"10.1016\/j.bone.2016.10.001_bb0405","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1161\/01.CIR.0000105723.91637.1C","article-title":"Cardiac-specific overexpression of fibroblast growth factor-2 protects against myocardial dysfunction and infarction in a murine model of low-flow ischemia","volume":"108","author":"House","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.bone.2016.10.001_bb0410","first-page":"109","article-title":"Effect of basic fibroblast growth factor on left ventricular geometry in rats subjected to coronary occlusion and reperfusion","volume":"4","author":"Scheinowitz","year":"2002","journal-title":"Isr. Med. Assoc. J."},{"key":"10.1016\/j.bone.2016.10.001_bb0415","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1161\/01.HYP.37.2.787","article-title":"Mineralocorticoid receptor affects AP-1 and nuclear factor-kappab activation in angiotensin II-induced cardiac injury","volume":"37","author":"Fiebeler","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.bone.2016.10.001_bb0420","first-page":"H826","article-title":"alpha1-Adrenergic stimulation of FGF-2 promoter in cardiac myocytes and in adult transgenic mouse hearts","volume":"276","author":"Detillieux","year":"1999","journal-title":"Am. J. Phys."},{"key":"10.1016\/j.bone.2016.10.001_bb0425","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1161\/01.RES.76.6.927","article-title":"Contraction-induced cell wounding and release of fibroblast growth factor in heart","volume":"76","author":"Clarke","year":"1995","journal-title":"Circ. Res."},{"key":"10.1016\/j.bone.2016.10.001_bb0430","doi-asserted-by":"crossref","first-page":"H547","DOI":"10.1152\/ajpheart.01019.2000","article-title":"Exacerbation of myocardial injury in transgenic mice overexpressing FGF-2 is T cell dependent","volume":"282","author":"Meij","year":"2002","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.bone.2016.10.001_bb0435","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1172\/JCI7315","article-title":"Fibroblast growth factor-2 mediates pressure-induced hypertrophic response","volume":"104","author":"Schultz","year":"1999","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bone.2016.10.001_bb0440","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.2353\/ajpath.2007.070003","article-title":"Fibroblast growth factor-2 regulates myocardial infarct repair: effects on cell proliferation, scar contraction, and ventricular function","volume":"171","author":"Virag","year":"2007","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bone.2016.10.001_bb0445","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11010-011-0868-4","article-title":"Protection by endogenous FGF-2 against isoproterenol-induced cardiac dysfunction is attenuated by cyclosporine A","volume":"357","author":"Jimenez","year":"2011","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.bone.2016.10.001_bb0450","doi-asserted-by":"crossref","first-page":"4213","DOI":"10.1093\/emboj\/17.15.4213","article-title":"Impaired cerebral cortex development and blood pressure regulation in FGF-2-deficient mice","volume":"17","author":"Dono","year":"1998","journal-title":"EMBO J."},{"key":"10.1016\/j.bone.2016.10.001_bb0455","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nm0298-201","article-title":"Fibroblast growth factor 2 control of vascular tone","volume":"4","author":"Zhou","year":"1998","journal-title":"Nat. Med."},{"key":"10.1016\/j.bone.2016.10.001_bb0460","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/BF01816946","article-title":"Basic fibroblast growth factor is cardioprotective in ischemia-reperfusion injury","volume":"143","author":"Padua","year":"1995","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.bone.2016.10.001_bb0465","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/S0003-4975(99)01557-X","article-title":"Therapeutic angiogenesis with intramyocardial administration of basic fibroblast growth factor","volume":"69","author":"Kawasuji","year":"2000","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.bone.2016.10.001_bb0470","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s10380-002-0686-5","article-title":"Intramyocardial sustained delivery of basic fibroblast growth factor improves angiogenesis and ventricular function in a rat infarct model","volume":"18","author":"Iwakura","year":"2003","journal-title":"Heart Vessel."},{"key":"10.1016\/j.bone.2016.10.001_bb0475","article-title":"Fibroblast growth factor 2 is an essential cardioprotective factor in a closed-chest model of cardiac ischemia-reperfusion injury","volume":"3","author":"House","year":"2015","journal-title":"Phys. Rep."},{"key":"10.1016\/j.bone.2016.10.001_bb0480","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/00024382-199907000-00004","article-title":"Reduction of infarct size in the rat heart by LPS preconditioning is associated with expression of angiogenic growth factors and increased capillary density","volume":"12","author":"Meng","year":"1999","journal-title":"Shock"},{"key":"10.1016\/j.bone.2016.10.001_bb0485","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1113\/expphysiol.1998.sp004140","article-title":"Basic fibroblast growth factor induces myocardial hypertrophy following acute infarction in rats","volume":"83","author":"Scheinowitz","year":"1998","journal-title":"Exp. Physiol."},{"key":"10.1016\/j.bone.2016.10.001_bb0490","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.yjmcc.2006.09.002","article-title":"High- but not low-molecular weight FGF-2 causes cardiac hypertrophy in vivo; possible involvement of cardiotrophin-1","volume":"42","author":"Jiang","year":"2007","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.bone.2016.10.001_bb0495","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1172\/JCI23418","article-title":"FGF-2 controls the differentiation of resident cardiac precursors into functional cardiomyocytes","volume":"115","author":"Rosenblatt-Velin","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bone.2016.10.001_bb0500","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1126\/science.1382313","article-title":"Salvage of infarcted myocardium by angiogenic action of basic fibroblast growth factor","volume":"257","author":"Yanagisawa-Miwa","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.bone.2016.10.001_bb0505","first-page":"H1588","article-title":"Basic fibroblast growth factor enhances myocardial collateral flow in a canine model","volume":"266","author":"Unger","year":"1994","journal-title":"Am. J. Phys."},{"key":"10.1016\/j.bone.2016.10.001_bb0510","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1172\/JCI114456","article-title":"Isolation, characterization, and localization of heparin-binding growth factors in the heart","volume":"85","author":"Casscells","year":"1990","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bone.2016.10.001_bb0515","first-page":"1336","article-title":"Fibroblast growth factors are present in adult cardiac myocytes, in vivo [corrected and issued with original paging in Biochem. Biophys. Res. Commun. 1988 Dec 30;157(3)]","volume":"159","author":"Speir","year":"1989","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bone.2016.10.001_bb0520","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1083\/jcb.109.4.1865","article-title":"Basic fibroblast growth factor in atria and ventricles of the vertebrate heart","volume":"109","author":"Kardami","year":"1989","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bone.2016.10.001_bb0525","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/PL00007264","article-title":"Myocardial ischemia enhances the expression of acidic fibroblast growth factor in human pericardial fluid","volume":"15","author":"Iwakura","year":"2000","journal-title":"Heart Vessel."},{"key":"10.1016\/j.bone.2016.10.001_bb0530","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1161\/01.RES.0000162099.01268.d1","article-title":"Adenoviral gene transfer of FGF-5 to hibernating myocardium improves function and stimulates myocytes to hypertrophy and reenter the cell cycle","volume":"96","author":"Suzuki","year":"2005","journal-title":"Circ. Res."},{"key":"10.1016\/j.bone.2016.10.001_bb0535","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1161\/CIRCULATIONAHA.110.989665","article-title":"Conditional transgenic expression of fibroblast growth factor 9 in the adult mouse heart reduces heart failure mortality after myocardial infarction","volume":"123","author":"Korf-Klingebiel","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.bone.2016.10.001_bb0540","doi-asserted-by":"crossref","first-page":"4251","DOI":"10.1128\/MCB.13.7.4251","article-title":"Molecular cloning of a novel cytokine cDNA encoding the ninth member of the fibroblast growth factor family, which has a unique secretion property","volume":"13","author":"Miyamoto","year":"1993","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bone.2016.10.001_bb0545","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cytogfr.2014.07.007","article-title":"Heart-specific expression of FGF-16 and a potential role in postnatal cardioprotection","volume":"26","author":"Wang","year":"2015","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.bone.2016.10.001_bb0550","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/s12012-013-9203-5","article-title":"FGF-2 and FGF-16 protect isolated perfused mouse hearts from acute doxorubicin-induced contractile dysfunction","volume":"13","author":"Sontag","year":"2013","journal-title":"Cardiovasc. Toxicol."},{"key":"10.1016\/j.bone.2016.10.001_bb0555","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/gtc.12055","article-title":"Angiotensin II-induced cardiac hypertrophy and fibrosis are promoted in mice lacking Fgf16","volume":"18","author":"Matsumoto","year":"2013","journal-title":"Genes Cells"},{"key":"10.1016\/j.bone.2016.10.001_bb0560","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.tig.2007.10.007","article-title":"Fibroblast growth factors and Hedgehogs: at the heart of the epicardial signaling center","volume":"24","author":"Lavine","year":"2008","journal-title":"Trends Genet."},{"key":"10.1016\/j.bone.2016.10.001_bb0565","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.cmet.2012.11.001","article-title":"Circulating fibroblast growth factors as metabolic regulators\u2013a critical appraisal","volume":"16","author":"Angelin","year":"2012","journal-title":"Cell Metab."},{"key":"10.1016\/j.bone.2016.10.001_bb0570","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.coph.2009.07.001","article-title":"FGFs and metabolism","volume":"9","author":"Kharitonenkov","year":"2009","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.bone.2016.10.001_bb0575","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0925-4773(00)00439-1","article-title":"Molecular cloning and expression analyses of mouse betaklotho, which encodes a novel klotho family protein","volume":"98","author":"Ito","year":"2000","journal-title":"Mech. Dev."},{"key":"10.1016\/j.bone.2016.10.001_bb0580","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/978-1-4614-0887-1_2","article-title":"Klotho and betaklotho","volume":"728","author":"Kuro-o","year":"2012","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.bone.2016.10.001_bb0585","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.tem.2014.10.002","article-title":"Tissue-specific actions of the metabolic hormones FGF15\/19 and FGF21","volume":"26","author":"Owen","year":"2015","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.bone.2016.10.001_bb0590","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.cmet.2005.09.001","article-title":"Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis","volume":"2","author":"Inagaki","year":"2005","journal-title":"Cell Metab."},{"key":"10.1016\/j.bone.2016.10.001_bb0595","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1101\/gad.1083503","article-title":"Definition of a novel growth factor-dependent signal cascade for the suppression of bile acid biosynthesis","volume":"17","author":"Holt","year":"2003","journal-title":"Genes Dev."},{"key":"10.1016\/j.bone.2016.10.001_bb0600","doi-asserted-by":"crossref","first-page":"11110","DOI":"10.1074\/jbc.M808747200","article-title":"FGF15\/FGFR4 integrates growth factor signaling with hepatic bile acid metabolism and insulin action","volume":"284","author":"Shin","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bone.2016.10.001_bb0605","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1016\/S0002-9440(10)61177-7","article-title":"A mouse model of hepatocellular carcinoma: ectopic expression of fibroblast growth factor 19 in skeletal muscle of transgenic mice","volume":"160","author":"Nicholes","year":"2002","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bone.2016.10.001_bb0610","doi-asserted-by":"crossref","first-page":"5165","DOI":"10.1074\/jbc.M109.068783","article-title":"FGF19-induced hepatocyte proliferation is mediated through FGFR4 activation","volume":"285","author":"Wu","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bone.2016.10.001_bb0615","doi-asserted-by":"crossref","first-page":"4057","DOI":"10.2337\/db14-0595","article-title":"Circulating FGF21 is liver derived and enhances glucose uptake during refeeding and overfeeding","volume":"63","author":"Markan","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.bone.2016.10.001_bb0620","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.cmet.2012.08.002","article-title":"betaKlotho is required for fibroblast growth factor 21 effects on growth and metabolism","volume":"16","author":"Ding","year":"2012","journal-title":"Cell Metab."},{"key":"10.1016\/j.bone.2016.10.001_bb0625","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0049977","article-title":"FGF21 requires betaklotho to act in vivo","volume":"7","author":"Adams","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bone.2016.10.001_bb0630","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.molmet.2012.08.007","article-title":"The breadth of FGF21's metabolic actions are governed by FGFR1 in adipose tissue","volume":"2","author":"Adams","year":"2012","journal-title":"Mol. Metab."},{"key":"10.1016\/j.bone.2016.10.001_bb0635","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3004690","article-title":"Treating diabetes and obesity with an FGF21-mimetic antibody activating the betaklotho\/FGFR1c receptor complex","volume":"4","author":"Foltz","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bone.2016.10.001_bb0640","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1101\/gad.177857.111","article-title":"FGF21 regulates PGC-1alpha and browning of white adipose tissues in adaptive thermogenesis","volume":"26","author":"Fisher","year":"2012","journal-title":"Genes Dev."},{"key":"10.1016\/j.bone.2016.10.001_bb0645","doi-asserted-by":"crossref","first-page":"250","DOI":"10.2337\/db08-0392","article-title":"Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice","volume":"58","author":"Xu","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.bone.2016.10.001_bb0650","doi-asserted-by":"crossref","first-page":"6018","DOI":"10.1210\/en.2008-0816","article-title":"Fibroblast growth factor 21 corrects obesity in mice","volume":"149","author":"Coskun","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/j.bone.2016.10.001_bb0655","doi-asserted-by":"crossref","first-page":"10853","DOI":"10.1073\/pnas.0904187106","article-title":"FGF21 induces PGC-1alpha and regulates carbohydrate and fatty acid metabolism during the adaptive starvation response","volume":"106","author":"Potthoff","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bone.2016.10.001_bb0660","doi-asserted-by":"crossref","first-page":"15947","DOI":"10.1074\/jbc.274.22.15947","article-title":"Specificity for fibroblast growth factors determined by heparan sulfate in a binary complex with the receptor kinase","volume":"274","author":"Kan","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bone.2016.10.001_bb0665","doi-asserted-by":"crossref","first-page":"27277","DOI":"10.1074\/jbc.M704244200","article-title":"Liver-specific activities of FGF19 require klotho beta","volume":"282","author":"Lin","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bone.2016.10.001_bb0670","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.diabres.2012.01.004","article-title":"Serum fibroblast growth factor 21 was elevated in subjects with type 2 diabetes mellitus and was associated with the presence of carotid artery plaques","volume":"96","author":"An","year":"2012","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.bone.2016.10.001_bb0675","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1365-2265.2008.03502.x","article-title":"Serum concentrations and tissue expression of a novel endocrine regulator fibroblast growth factor-21 in patients with type 2 diabetes and obesity","volume":"71","author":"Mraz","year":"2009","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.bone.2016.10.001_bb0680","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.2337\/dc09-0684","article-title":"Circulating fibroblast growth factor-21 is elevated in impaired glucose tolerance and type 2 diabetes and correlates with muscle and hepatic insulin resistance","volume":"32","author":"Chavez","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.bone.2016.10.001_bb0685","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.2337\/db07-1476","article-title":"Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans","volume":"57","author":"Zhang","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.bone.2016.10.001_bb0690","doi-asserted-by":"crossref","first-page":"E1197","DOI":"10.1152\/ajpendo.00357.2009","article-title":"A very low carbohydrate ketogenic diet improves glucose tolerance in ob\/ob mice independently of weight loss","volume":"297","author":"Badman","year":"2009","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2016.10.001_bb0695","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1210\/en.2010-1262","article-title":"Lack of overt FGF21 resistance in two mouse models of obesity and insulin resistance","volume":"153","author":"Hale","year":"2012","journal-title":"Endocrinology"},{"key":"10.1016\/j.bone.2016.10.001_bb0700","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.2337\/db11-0112","article-title":"Nrf2 represses FGF21 during long-term high-fat diet-induced obesity in mice","volume":"60","author":"Chartoumpekis","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.bone.2016.10.001_bb0705","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.2337\/db10-0193","article-title":"Obesity is a fibroblast growth factor 21 (FGF21)-resistant state","volume":"59","author":"Fisher","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.bone.2016.10.001_bb0710","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2015.02.032","article-title":"The role of fibroblast growth factor 21 in diabetes and its complications: a review from clinical perspective","author":"Liu","year":"2015","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.bone.2016.10.001_bb0715","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1681\/ASN.2007010068","article-title":"How fibroblast growth factor 23 works","volume":"18","author":"Liu","year":"2007","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bone.2016.10.001_bb0720","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1681\/ASN.2007121301","article-title":"FGFR3 and FGFR4 do not mediate renal effects of FGF23","volume":"19","author":"Liu","year":"2008","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bone.2016.10.001_bb0725","doi-asserted-by":"crossref","first-page":"F282","DOI":"10.1152\/ajprenal.90742.2008","article-title":"FGF23 decreases renal NaPi-2a and NaPi-2c expression and induces hypophosphatemia in vivo predominantly via FGF receptor 1","volume":"297","author":"Gattineni","year":"2009","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.bone.2016.10.001_bb0730","doi-asserted-by":"crossref","first-page":"E508","DOI":"10.1152\/ajpendo.00499.2010","article-title":"Compound deletion of Fgfr3 and Fgfr4 partially rescues the Hyp mouse phenotype","volume":"300","author":"Li","year":"2011","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2016.10.001_bb0735","doi-asserted-by":"crossref","first-page":"F371","DOI":"10.1152\/ajprenal.00740.2010","article-title":"Regulation of serum 1,25(OH)2 vitamin D3 levels by fibroblast growth factor 23 is mediated by FGF receptors 3 and 4","volume":"301","author":"Gattineni","year":"2011","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.bone.2016.10.001_bb0740","doi-asserted-by":"crossref","first-page":"F351","DOI":"10.1152\/ajprenal.00232.2013","article-title":"Regulation of renal phosphate transport by FGF23 is mediated by FGFR1 and FGFR4","volume":"306","author":"Gattineni","year":"2014","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.bone.2016.10.001_bb0745","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1681\/ASN.2012010048","article-title":"Targeted deletion of klotho in kidney distal tubule disrupts mineral metabolism","volume":"23","author":"Olauson","year":"2012","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bone.2016.10.001_bb0750","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1681\/ASN.2013111209","article-title":"The kidney is the principal organ mediating klotho effects","volume":"25","author":"Lindberg","year":"2014","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bone.2016.10.001_bb0755","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1074\/jbc.M408903200","article-title":"Circulating FGF-23 is regulated by 1alpha,25-dihydroxyvitamin D3 and phosphorus in vivo","volume":"280","author":"Saito","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bone.2016.10.001_bb0760","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1359\/JBMR.0301264","article-title":"FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis","volume":"19","author":"Shimada","year":"2004","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2016.10.001_bb0765","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/MNH.0b013e3281ca6ffd","article-title":"Emerging role of fibroblast growth factor 23 in a bone-kidney axis regulating systemic phosphate homeostasis and extracellular matrix mineralization","volume":"16","author":"Liu","year":"2007","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"10.1016\/j.bone.2016.10.001_bb0770","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1152\/ajpendo.00016.2003","article-title":"FGF23, PHEX, and MEPE regulation of phosphate homeostasis and skeletal mineralization","volume":"285","author":"Quarles","year":"2003","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2016.10.001_bb0775","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1681\/ASN.2005111185","article-title":"Fibroblast growth factor 23 is a counter-regulatory phosphaturic hormone for vitamin D","volume":"17","author":"Liu","year":"2006","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bone.2016.10.001_bb0780","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1038\/ncomms3019","article-title":"Fibroblast growth factor 21 protects against cardiac hypertrophy in mice","volume":"4","author":"Planavila","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bone.2016.10.001_bb0785","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1038\/srep02767","article-title":"Endocrine protection of ischemic myocardium by FGF21 from the liver and adipose tissue","volume":"3","author":"Liu","year":"2013","journal-title":"Sci. Report."},{"key":"10.1016\/j.bone.2016.10.001_bb0790","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.bbrc.2015.02.081","article-title":"FGF21 attenuates pathological myocardial remodeling following myocardial infarction through the adiponectin-dependent mechanism","volume":"459","author":"Joki","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bone.2016.10.001_bb0795","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/cvr\/cvu263","article-title":"Fibroblast growth factor 21 protects the heart from oxidative stress","volume":"106","author":"Planavila","year":"2015","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bone.2016.10.001_bb0800","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0087102","article-title":"Novel insights into the cardio-protective effects of FGF21 in lean and obese rat hearts","volume":"9","author":"Patel","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.bone.2016.10.001_bb0805","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/apha.12698","article-title":"Fibroblast growth factor 21 (FGF21) therapy attenuates left ventricular dysfunction and metabolic disturbance by improving FGF21 sensitivity, cardiac mitochondrial redox homoeostasis and structural changes in pre-diabetic rats","volume":"217","author":"Tanajak","year":"2016","journal-title":"Acta Physiol (Oxford)"},{"key":"10.1016\/j.bone.2016.10.001_bb0810","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1111\/jcmm.12530","article-title":"FGF21 deletion exacerbates diabetic cardiomyopathy by aggravating cardiac lipid accumulation","volume":"19","author":"Yan","year":"2015","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.bone.2016.10.001_bb0815","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1194\/jlr.M044784","article-title":"Fibroblast growth factor 21 is induced upon cardiac stress and alters cardiac lipid homeostasis","volume":"55","author":"Brahma","year":"2014","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bone.2016.10.001_bb0820","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1007\/s00125-015-3630-8","article-title":"Fibroblast growth factor 21 protects the heart from apoptosis in a diabetic mouse model via extracellular signal-regulated kinase 1\/2-dependent signalling pathway","volume":"58","author":"Zhang","year":"2015","journal-title":"Diabetologia"},{"key":"10.1016\/j.bone.2016.10.001_bb0825","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/jhh.2012.52","article-title":"Elevated serum fibroblast growth factor 21 is associated with hypertension in community-dwelling adults","volume":"27","author":"Semba","year":"2013","journal-title":"J. Hum. Hypertens."},{"key":"10.1016\/j.bone.2016.10.001_bb0830","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/1475-2840-12-124","article-title":"Additive relationship between serum fibroblast growth factor 21 level and coronary artery disease","volume":"12","author":"Shen","year":"2013","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.bone.2016.10.001_bb0835","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0015534","article-title":"Serum levels of FGF-21 are increased in coronary heart disease patients and are independently associated with adverse lipid profile","volume":"5","author":"Lin","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.bone.2016.10.001_bb0840","article-title":"Serum level of fibroblast growth factor 21 is independently associated with acute myocardial infarction","volume":"10","author":"Zhang","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.bone.2016.10.001_bb0845","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.cyto.2015.02.019","article-title":"Serum fibroblast growth factor 21 levels are increased in atrial fibrillation patients","volume":"73","author":"Han","year":"2015","journal-title":"Cytokine"},{"key":"10.1016\/j.bone.2016.10.001_bb0850","first-page":"14901","article-title":"Fibroblast growth factor-21 is positively associated with atrial fibrosis in atrial fibrillation patients with rheumatic heart disease","volume":"8","author":"Wang","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.bone.2016.10.001_bb0855","doi-asserted-by":"crossref","first-page":"33953","DOI":"10.1038\/srep33953","article-title":"Circulating fibroblast growth factor 21 is associated with diastolic dysfunction in heart failure patients with preserved ejection fraction","volume":"6","author":"Chou","year":"2016","journal-title":"Sci. Report."},{"key":"10.1016\/j.bone.2016.10.001_bb0860","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.diabres.2013.04.010","article-title":"Serum fibroblast growth factor 21 is predictive of combined cardiovascular morbidity and mortality in patients with type 2 diabetes at a relatively short-term follow-up","volume":"101","author":"Lenart-Lipinska","year":"2013","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.bone.2016.10.001_bb0865","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1007\/s00125-014-3458-7","article-title":"The relationship of fibroblast growth factor 21 with cardiovascular outcome events in the Fenofibrate intervention and event lowering in diabetes study","volume":"58","author":"Ong","year":"2015","journal-title":"Diabetologia"},{"key":"10.1016\/j.bone.2016.10.001_bb0870","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1042\/CS20150623","article-title":"Fenofibrate increases cardiac autophagy via FGF21\/SIRT1 and prevents fibrosis and inflammation in the hearts of type 1 diabetic mice","volume":"130","author":"Zhang","year":"2016","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.bone.2016.10.001_bb0875","doi-asserted-by":"crossref","first-page":"E863","DOI":"10.1152\/ajpendo.00596.2012","article-title":"FGF23 is a novel regulator of intracellular calcium and cardiac contractility in addition to cardiac hypertrophy","volume":"304","author":"Touchberry","year":"2013","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2016.10.001_bb0880","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.1172\/JCI46122","article-title":"FGF23 induces left ventricular hypertrophy","volume":"121","author":"Faul","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bone.2016.10.001_bb0885","article-title":"Klotho and phosphate are modulators of pathologic uremic cardiac remodeling","author":"Hu","year":"2014","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bone.2016.10.001_bb0890","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/HJH.0b013e32835b15bb","article-title":"Cardiovascular disease in an adenine-induced model of chronic kidney disease: the temporal link between vascular calcification and haemodynamic consequences","volume":"31","author":"Shobeiri","year":"2013","journal-title":"J. Hypertens."},{"key":"10.1016\/j.bone.2016.10.001_bb0895","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/MNH.0b013e32835422c4","article-title":"Fibroblast growth factor 23 and the heart","volume":"21","author":"Faul","year":"2012","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"10.1016\/j.bone.2016.10.001_bb0900","doi-asserted-by":"crossref","first-page":"4647","DOI":"10.1210\/en.2005-0670","article-title":"Analysis of the biochemical mechanisms for the endocrine actions of fibroblast growth factor-23","volume":"146","author":"Yu","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.bone.2016.10.001_bb0905","doi-asserted-by":"crossref","first-page":"29134","DOI":"10.1074\/jbc.M112.342980","article-title":"Conversion of a paracrine fibroblast growth factor into an endocrine fibroblast growth factor","volume":"287","author":"Goetz","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bone.2016.10.001_bb0910","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1001\/jama.298.17.2038","article-title":"Prevalence of chronic kidney disease in the United States","volume":"298","author":"Coresh","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.bone.2016.10.001_bb0915","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization","volume":"351","author":"Go","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bone.2016.10.001_bb0920","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/0272-6386(95)90177-9","article-title":"Death risk predictors among peritoneal dialysis and hemodialysis patients: a preliminary comparison","volume":"26","author":"Lowrie","year":"1995","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.bone.2016.10.001_bb0925","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1046\/j.1523-1755.1998.00005.x","article-title":"\"U\" curve association of blood pressure and mortality in hemodialysis patients. Medical Directors of Dialysis Clinic, Inc.","volume":"54","author":"Zager","year":"1998","journal-title":"Kidney Int."},{"key":"10.1016\/j.bone.2016.10.001_bb0930","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/j.1525-139X.2008.00454.x","article-title":"Hypertrophy and fibrosis in the cardiomyopathy of uremia-beyond coronary heart disease","volume":"21","author":"Gross","year":"2008","journal-title":"Semin. Dial."},{"key":"10.1016\/j.bone.2016.10.001_bb0935","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/ki.1985.197","article-title":"Myocardial hypertrophy in rats with renal insufficiency","volume":"28","author":"Rambausek","year":"1985","journal-title":"Kidney Int."},{"key":"10.1016\/j.bone.2016.10.001_bb0940","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/ki.2008.690","article-title":"Uremic cardiac hypertrophy is reversed by rapamycin but not by lowering of blood pressure","volume":"75","author":"Siedlecki","year":"2009","journal-title":"Kidney Int."},{"key":"10.1016\/j.bone.2016.10.001_bb0945","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/ki.2009.35","article-title":"Left ventricular hypertrophy in renal disease: beyond preload and afterload","volume":"75","author":"Ritz","year":"2009","journal-title":"Kidney Int."},{"key":"10.1016\/j.bone.2016.10.001_bb0950","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1161\/CIRCULATIONAHA.108.844506","article-title":"Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease","volume":"119","author":"Gutierrez","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.bone.2016.10.001_bb0955","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1093\/ndt\/gfq309","article-title":"FGF-23 and future cardiovascular events in patients with chronic kidney disease before initiation of dialysis treatment","volume":"25","author":"Seiler","year":"2010","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.bone.2016.10.001_bb0960","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJMoa0706130","article-title":"Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis","volume":"359","author":"Gutierrez","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bone.2016.10.001_bb0965","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1001\/jama.2011.826","article-title":"Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease","volume":"305","author":"Isakova","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.bone.2016.10.001_bb0970","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1681\/ASN.2010121224","article-title":"FGF-23 associates with death, cardiovascular events, and initiation of chronic dialysis","volume":"22","author":"Kendrick","year":"2010","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bone.2016.10.001_bb0975","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/MAJ.0b013e3181815498","article-title":"Fibroblast growth factor 23: a possible cause of left ventricular hypertrophy in hemodialysis patients","volume":"337","author":"Hsu","year":"2009","journal-title":"Am. J. Med. Sci."},{"key":"10.1016\/j.bone.2016.10.001_bb0980","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1093\/ndt\/gfq539","article-title":"Serum fibroblast growth factor-23 (FGF-23) levels are independently associated with left ventricular mass and myocardial performance index in maintenance haemodialysis patients","volume":"26","author":"Kirkpantur","year":"2011","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.bone.2016.10.001_bb0985","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1007\/s00467-012-2224-7","article-title":"Fibroblast growth factor 23 and left ventricular hypertrophy in children on dialysis","volume":"27","author":"Seeherunvong","year":"2012","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.bone.2016.10.001_bb0990","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1093\/ndt\/gfu190","article-title":"Treatment of established left ventricular hypertrophy with fibroblast growth factor receptor blockade in an animal model of CKD","volume":"29","author":"Di Marco","year":"2014","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.bone.2016.10.001_bb0995","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1681\/ASN.2012030223","article-title":"Effects of phosphate binders in moderate CKD","volume":"23","author":"Block","year":"2012","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bone.2016.10.001_bb1000","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1172\/JCI61405","article-title":"FGF23 neutralization improves chronic kidney disease-associated hyperparathyroidism yet increases mortality","volume":"122","author":"Shalhoub","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bone.2016.10.001_bb1005","doi-asserted-by":"crossref","first-page":"3615","DOI":"10.1242\/dev.125.18.3615","article-title":"FGFR-3 and FGFR-4 function cooperatively to direct alveogenesis in the murine lung","volume":"125","author":"Weinstein","year":"1998","journal-title":"Development"},{"key":"10.1016\/j.bone.2016.10.001_bb1010","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1164\/rccm.200904-0544OC","article-title":"Fibroblast growth factor receptors control epithelial-mesenchymal interactions necessary for alveolar elastogenesis","volume":"181","author":"Srisuma","year":"2010","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.bone.2016.10.001_bb1015","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1172\/JCI83470","article-title":"FGF23 signaling impairs neutrophil recruitment and host defense during CKD","volume":"126","author":"Rossaint","year":"2016","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bone.2016.10.001_bb1020","doi-asserted-by":"crossref","DOI":"10.1016\/j.kint.2016.05.019","article-title":"Fibroblast growth factor 23 directly targets hepatocytes to promote inflammation in chronic kidney disease","author":"Singh","year":"2016","journal-title":"Kidney Int."},{"key":"10.1016\/j.bone.2016.10.001_bb1025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0044161","article-title":"A comparative transcriptome analysis identifying FGF23 regulated genes in the kidney of a mouse CKD model","volume":"7","author":"Dai","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bone.2016.10.001_bb1030","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1248\/bpb.b14-00276","article-title":"Expression of Fgf23 in activated dendritic cells and macrophages in response to immunological stimuli in mice","volume":"38","author":"Masuda","year":"2015","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.bone.2016.10.001_bb1035","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/1873-3468.12040","article-title":"Counter-regulatory paracrine actions of FGF-23 and 1,25(OH)2 D in macrophages","volume":"590","author":"Han","year":"2016","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bone.2016.10.001_bb1040","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2016.03.138","article-title":"Wound healing delays in alpha-klotho-deficient mice that have skin appearance similar to that in aged humans - study of delayed wound healing mechanism","author":"Yamauchi","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bone.2016.10.001_bb1045","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1159\/000355811","article-title":"Cardiac and renal effects of atrasentan in combination with enalapril and paricalcitol in uremic rats","volume":"39","author":"Ritter","year":"2014","journal-title":"Kidney Blood Press. Res."},{"key":"10.1016\/j.bone.2016.10.001_bb1050","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/ki.2013.110","article-title":"Effects of sevelamer treatment on cardiovascular abnormalities in mice with chronic renal failure","volume":"84","author":"Maizel","year":"2013","journal-title":"Kidney Int."},{"key":"10.1016\/j.bone.2016.10.001_bb1055","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1161\/HYPERTENSIONAHA.109.140038","article-title":"Spironolactone attenuates experimental uremic cardiomyopathy by antagonizing marinobufagenin","volume":"54","author":"Tian","year":"2009","journal-title":"Hypertension"},{"key":"10.1016\/j.bone.2016.10.001_bb1060","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1161\/CIRCRESAHA.112.278457","article-title":"Cardiorenal syndrome: the emerging role of protein-bound uremic toxins","volume":"111","author":"Lekawanvijit","year":"2012","journal-title":"Circ. Res."},{"key":"10.1016\/j.bone.2016.10.001_bb1065","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1002\/emmm.201303716","article-title":"FGF23 regulates renal sodium handling and blood pressure","volume":"6","author":"Andrukhova","year":"2014","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.bone.2016.10.001_bb1070","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1093\/eurheartj\/ehr215","article-title":"The phosphatonin fibroblast growth factor 23 links calcium-phosphate metabolism with left-ventricular dysfunction and atrial fibrillation","volume":"32","author":"Seiler","year":"2011","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.bone.2016.10.001_bb1075","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1007\/s00467-013-2515-7","article-title":"Associations between fibroblast growth factor 23 and cardiac characteristics in pediatric heart failure","volume":"28","author":"Isakova","year":"2013","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.bone.2016.10.001_bb1080","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/13086f84-18f2-4ea3-881a-0484b0c411ee","article-title":"Association between circulating fibroblast growth factor 23, alpha-klotho, and the left ventricular ejection fraction and left ventricular mass in cardiology inpatients","volume":"8","author":"Shibata","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bone.2016.10.001_bb1085","doi-asserted-by":"crossref","first-page":"H1504","DOI":"10.1152\/ajpheart.00331.2014","article-title":"Pathophysiological impact of serum fibroblast growth factor 23 in patients with nonischemic cardiac disease and early chronic kidney disease","volume":"307","author":"Imazu","year":"2014","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.bone.2016.10.001_bb1090","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.jchf.2015.05.012","article-title":"Association of Fibroblast Growth Factor-23 levels and angiotensin-converting enzyme inhibition in chronic systolic heart failure","volume":"3","author":"Wohlfahrt","year":"2015","journal-title":"JACC Heart Fail."},{"key":"10.1016\/j.bone.2016.10.001_bb1095","article-title":"Elevation of circulating but not myocardial FGF23 in human acute decompensated heart failure","author":"Andersen","year":"2015","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.bone.2016.10.001_bb1100","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1002\/jbmr.2527","article-title":"Experimental myocardial infarction upregulates circulating fibroblast growth factor-23","volume":"30","author":"Andrukhova","year":"2015","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2016.10.001_bb1105","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.mce.2014.10.007","article-title":"Regulation of FGF23 expression in IDG-SW3 osteocytes and human bone by pro-inflammatory stimuli","volume":"399","author":"Ito","year":"2015","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.bone.2016.10.001_bb1110","article-title":"Inflammation and functional iron deficiency regulate fibroblast growth factor 23 production","author":"David","year":"2015","journal-title":"Kidney Int."},{"key":"10.1016\/j.bone.2016.10.001_bb1115","doi-asserted-by":"crossref","DOI":"10.1007\/s00223-016-0116-8","article-title":"Systemic inflammation affects human osteocyte-specific protein and cytokine expression","author":"Pathak","year":"2016","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.bone.2016.10.001_bb1120","article-title":"Oncostatin M induces FGF23 expression in cardiomyocytes","volume":"S:9","author":"Richter","year":"2012","journal-title":"J. Clin. Exp. Cardiolog."},{"key":"10.1016\/j.bone.2016.10.001_bb1125","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.healun.2015.06.007","article-title":"The failing heart is a major source of circulating FGF23 via oncostatin M receptor activation","volume":"34","author":"Richter","year":"2015","journal-title":"J. Heart Lung Transplant."},{"key":"10.1016\/j.bone.2016.10.001_bb1130","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1161\/ATVBAHA.114.303508","article-title":"S100\/Calgranulin-mediated inflammation accelerates left ventricular hypertrophy and aortic valve sclerosis in chronic kidney disease in a receptor for advanced glycation end products-dependent manner","volume":"34","author":"Yan","year":"2014","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bone.2016.10.001_bb1135","article-title":"Chronic sustained inflammation links to left ventricular hypertrophy and aortic valve sclerosis: a new link between S100\/RAGE and FGF23","volume":"1","author":"Yan","year":"2014","journal-title":"Inflamm. Cell Signal."},{"key":"10.1016\/j.bone.2016.10.001_bb1140","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1161\/01.cir.0000441139.02102.80","article-title":"Heart disease and stroke statistics\u20132014 update: a report from the American Heart Association","volume":"129","author":"Go","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.bone.2016.10.001_bb1145","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.114.001598","article-title":"Apocynin attenuates cardiac injury in type 4 Cardiorenal syndrome via suppressing cardiac fibroblast growth factor-2 with oxidative stress inhibition","volume":"4","author":"Liu","year":"2015","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.bone.2016.10.001_bb1150","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1055\/s-0029-1243249","article-title":"Fibroblast growth factor 19 serum levels: relation to renal function and metabolic parameters","volume":"42","author":"Reiche","year":"2010","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.bone.2016.10.001_bb1155","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1016\/j.metabol.2010.03.018","article-title":"Serum fibroblast growth factor-21 concentration is associated with residual renal function and insulin resistance in end-stage renal disease patients receiving long-term peritoneal dialysis","volume":"59","author":"Han","year":"2010","journal-title":"Metabolism"},{"key":"10.1016\/j.bone.2016.10.001_bb1160","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1111\/cen.12380","article-title":"Serum levels of fibroblast growth factor-21 are increased in chronic and acute renal dysfunction","volume":"80","author":"Hindricks","year":"2014","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.bone.2016.10.001_bb1165","doi-asserted-by":"crossref","first-page":"126","DOI":"10.2337\/dc08-1054","article-title":"Serum levels of the adipokine FGF21 depend on renal function","volume":"32","author":"Stein","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.bone.2016.10.001_bb1170","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1111\/j.1532-5415.2011.03879.x","article-title":"Serum fibroblast growth factor 21 is associated with renal function and chronic kidney disease in community-dwelling adults","volume":"60","author":"Crasto","year":"2012","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.bone.2016.10.001_bb1175","article-title":"Circulating FGF21 levels are progressively increased from the early to end stages of chronic kidney diseases and are associated with renal function in Chinese","volume":"6","author":"Lin","year":"2011","journal-title":"PLoS One"}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328216302824?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328216302824?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,10]],"date-time":"2022-07-10T02:35:31Z","timestamp":1657420531000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328216302824"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":235,"alternative-id":["S8756328216302824"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2016.10.001","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiac actions of fibroblast growth factor 23","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2016.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}